Medical Device and Diagnostic Industry (MD+DI)Opinion

Dexcom Learns a Lesson in Transparency

Customers have known for months that the Dexcom G7 continuous glucose monitoring sensor had problems. Now, the company is ...
Benzinga.com

Short Report Alleges Dexcom Sold Faulty G7 Device Cited By FDA

Hunterbrook Media released a short report on diabetes-focused DexCom Inc. (NASDAQ:DXCM), citing that the company sold the "adulterated" device. Benzinga reached out to DexCom for comments and is yet ...
TechRepublic

Dexcom Warns Stolen G7 Glucose Sensors May Pose Infection, Reading Risks

Dexcom says stolen G7 sensors from two scrapped lots were sold through unauthorized channels, creating infection and reading-failure risks. Medical device maker Dexcom says two lots of its Dexcom G7 ...
FierceBiotech

Dexcom receives FDA warning letter over CGM manufacturing issues

The admonition came after the FDA found inadequate procedures for tracking design changes, as well as design validation and risk analyses. (Sarah Silbiger/Stringer/Getty Images) Dexcom has received a ...
Medscape

Dexcom Issues Recall for G7, ONE+ Apps for Software Issues

Dexcom, Inc, has issued a recall for G7 Apps and ONE+ Apps because of a software design error failing to alert users of unexpected sensor failures. This recall ...